Skip to content

The Taiwan OSA Study

Clinical Features of Obstructive Sleep Apnea Patients With Different Phenotypes

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07302685
Acronym
TOSA
Enrollment
7000
Registered
2025-12-24
Start date
2020-04-10
Completion date
2032-02-28
Last updated
2025-12-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive Sleep Apnea

Brief summary

We will prospectively recruit 7000 OSA patients referred to the sleep center or China Medical University Hospital between 2020 and 2027. Polysomnographic (PSG) study data, clinical features, and health data from the National Health Insurance Research Database will be linked. Endotypic traits will be determined by PSG study parameters. The associations between clinical features, endotypic traits, and health outcome will be examined. Some patients will be invited to receive lung function tests, blood serum tests, blood gas tests, and cognitive function tests.

Interventions

None listed

Sponsors

China Medical University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
0 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* patients who are referred to China Medical University Hospital sleep center by physicians

Exclusion criteria

-Individuals unable to complete at least 6 hours of PSG examination

Design outcomes

Primary

MeasureTime frameDescription
Health outcomeWithin 20 years from the date of the PSG examinationRegistered diagnosis in the National Health Insurance Database

Secondary

MeasureTime frameDescription
Sleep qualityBaselinePittsburgh Sleep Quality Index (PSQI) ranges from 0 (better) to 21 (worse).
Daytime sleepinessBaselineEpworth Sleepiness Scale ranges from 0 (better) to 24 (worse)

Countries

Taiwan

Contacts

Primary ContactWan-Ju Cheng, Doctor
s871065@gmail.com+1872 +886422052121

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026